{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:38:57Z","timestamp":1762868337245,"version":"3.37.3"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T00:00:00Z","timestamp":1608940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81922012"],"award-info":[{"award-number":["81922012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"DOI":"10.1093\/rheumatology\/keaa848","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T20:26:42Z","timestamp":1606768002000},"page":"e200-e202","source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment by thalidomide therapy of intestinal Beh\u00e7et\u2019s disease associated with trisomy 8 myelodysplastic syndrome"],"prefix":"10.1093","volume":"60","author":[{"given":"Qinglin","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Burn Research, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangnian","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Hematology, Southwest Hospital, Army Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingqin","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for Hematology, Southwest Hospital, Army Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoling","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Southwest Hospital, Cholestatic Liver Diseases Center (CLDC), Army Medical, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,26]]},"reference":[{"key":"2021061821313550500_keaa848-B1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021061821313550500_keaa848-B2","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"2021061821313550500_keaa848-B3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"2021061821313550500_keaa848-B4","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.2174\/0929867322666150209161448","article-title":"Currently used biologic agents in the management of Behcet's Syndrome","volume":"22","author":"Saygin","year":"2015","journal-title":"Curr Med Chem"},{"key":"2021061821313550500_keaa848-B5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et's disease: multicenter study of 124 patients","volume":"62","author":"Vallet","year":"2015","journal-title":"J Autoimmun"},{"key":"2021061821313550500_keaa848-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"2021061821313550500_keaa848-B7","first-page":"S129","article-title":"TNF-alpha antagonists and thalidomide for the management of gastrointestinal Beh\u00e7et's syndrome refractory to the conventional treatment modalities: a case series and review of the literature","volume":"33","author":"Hatemi","year":"2015","journal-title":"Clinical and experimental rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa848\/34944653\/keaa848.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/e200\/38695222\/keaa848.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/e200\/38695222\/keaa848.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T21:34:48Z","timestamp":1624052088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/e200\/6040752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,26]]},"references-count":7,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,12,26]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa848","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,12,26]]}}}